Real-time Biomarker Assessment and Disease Monitoring Through Circulating Tumor Cells
The Parsortix Platform by CelLBxHealth is a next-generation microfluidic system designed to enrich and recover viable circulating tumor cells (CTCs) and CTC clusters from whole blood.
Using patented, marker-independent technology within a single-use cassette, the Parsortix Platform isolates cells based on size and deformability enabling the capture of a broad range of phenotypes, including mesenchymal and EMT-transitioning cells often missed by marker-dependent methods.
The Parsortix Platform supports:
Real-time biomarker assessment
Therapy selection and resistance monitoring
Tumor evolution studies through repeatable, minimally invasive sampling
Drug discovery and development
Complementary analysis alongside ctDNA
Flexibility to Meet Your Needs
Bring the Parsortix Platform into Your Laboratory
- Semi-automated microfluidic processing
- Cost-effective and repeatable liquid biopsy testing
- Integration into existing research workflows
Or Partner with CelLBxHealth Lab Services
Our expert team will work with you to support your project using cutting-edge technology, eliminating the burden of capital equipment and operator training to provide:
- Custom assay development for real time biomarker assessment
- CTC enrichment using the Parsortix Platform
- Comprehensive downstream analysis
Discover Publications & Resources
Scientific Evidence
Discover More
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer
Open PDF